📰 John Aballi News
John Aballi News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from John Aballi. Real-time updates on events, politics, business and more.
May 6, 2024
CARLSBAD, Calif., May 06, 2024 -- Exagen Inc. , a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a campaign focusing on...
May 1, 2024
CARLSBAD, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (NASDAQ:XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended March 31, 2024, before the market opens on
April 29, 2024
CARLSBAD, Calif. - Exagen Inc. , a leading provider of autoimmune testing solutions, today announced changes to the Board of Directors. Exagen is pleased to announce Scott Kahn, Ph.D. is joining the...
April 26, 2024
CARLSBAD, Calif., April 26, 2024 -- Exagen Inc. , a leading provider of autoimmune testing solutions, today announced changes to the Board of Directors. Exagen is pleased to announce Scott Kahn,...
January 30, 2024
CARLSBAD, Calif., Jan. 30, 2024 -- Exagen Inc. , a leading provider of autoimmune testing solutions, today announced its participation in the BTIG MedTech, Digital Health, Life Science &...
January 13, 2024
Exagen Inc. (NASDAQ:XGN – Get Free Report) was the recipient of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 24,200 shares, a growth of 633.3% from the December 15th total of 3,300 shares. Based on an average trading volume of 48,200 shares, the […]
January 11, 2024
Exagen Inc. (NASDAQ:XGN – Get Free Report) was the recipient of a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 24,200 shares, a growth of 633.3% from the December 15th total of 3,300 shares. Approximately 0.3% of the company’s shares are short sold. Based […]
January 8, 2024
CARLSBAD, Calif., Jan. 07, 2024 -- Exagen Inc. , a leading provider of autoimmune testing solutions, today announces select preliminary unaudited financial results for the full year ended...
January 7, 2024
CARLSBAD, Calif., Jan. 07, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announces select...
January 7, 2024
CARLSBAD, Calif., Jan. 07, 2024 -- Exagen Inc. , a leading provider of autoimmune testing solutions, today announces select preliminary unaudited financial results for the full year ended...